A clinical trial to study effect ofYavani formulations on Menstrual Pai
Phase 2
Completed
- Conditions
- Health Condition 1: N719- Inflammatory disease of uterus, unspecified
- Registration Number
- CTRI/2020/10/028604
- Lead Sponsor
- Dr Mauli Vaishnav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 216
Inclusion Criteria
1. Patients complaining painful menstruation at least two consecutive cycles.
2. Patient having regular menstrual cycle.
Exclusion Criteria
1. Acute infection,
2. Acyclic and excessive bleeding more than 4 pads/day or more than 5days.
3. Any pelvic pathology leading to dysmenorrhoea
4. Intra Uterine Contraceptive Device induced painful bleeding
5. All secondary causes leading to dysmenorrhoea
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Various kalpana of Yavani can be 70 % effective on Udavartini Yonivyapad WSR to Primary Dysmenorrhoea. <br/ ><br>Timepoint: After completion of 3 cycle of menstruation and 5 cycles of menstruation <br/ ><br> <br/ ><br>on the 4th day of menstrual cycle
- Secondary Outcome Measures
Name Time Method Various kalpana of Yavani can provide 80 % beneficial effect on in pain during menstruation and provides beneficial effect on digestive system.Timepoint: on 3rd day of menstrual cycle <br/ ><br>